Opko Health
OPK
212 hedge funds and large institutions have $721M invested in Opko Health in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 73 increasing their positions, 61 reducing their positions, and 31 closing their positions.
101% more call options, than puts
Call options by funds: $27M | Put options by funds: $13.4M
20% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 61
13% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 31
6% more capital invested
Capital invested by funds: $680M → $721M (+$41.4M)
1% more funds holding
Funds holding: 210 → 212 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.57% less ownership
Funds ownership: 29.76% → 29.19% (-0.57%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$14.7M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.2M |
| 3 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
+$6.68M |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$6.04M |
| 5 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$5.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$28.4M |
| 2 |
State Street
Boston,
Massachusetts
|
-$22.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.77M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$4.66M |
| 5 |
BlackRock
New York
|
-$4.41M |
OPK Hedge Fund Activity: Q3 2020 in Review
212 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q3 2020, worth a combined $721M — up 6.1% from $680M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new OPK positions and 31 closed out — a net gain of 4 holders — while 73 added to existing stakes and 61 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $14.7M. The largest seller was Citadel Advisors, cutting an estimated $28.4M.
- 212 institutional investors held Opko Health (OPK) as of Q3 2020, up from 210 in Q2 2020.
- Funds reported $721M of Opko Health stock for Q3 2020, up 6.1% quarter-over-quarter.
- 35 funds opened new Opko Health positions in Q3 2020 and 31 closed out, a net change of +4 holders.
- The largest Opko Health buyer in Q3 2020 was Goldman Sachs, an estimated $14.7M added.
- The largest Opko Health seller in Q3 2020 was Citadel Advisors, an estimated $28.4M sold.
Based on aggregated 13F filings for Q3 2020.